Cannabinoid receptor type 2 agonist JWH-133 decreases cathepsin B secretion and neurotoxicity from HIV-infected macrophages.

Rosario-Rodr?guez LJ, Gerena Y, Garc?a-Requena LA, Cartagena-Isern LJ, Cuadrado-Ruiz JC, Borges-V?lez G, Mel?ndez LM. Cannabinoid receptor type 2 agonist JWH-133 decreases cathepsin B secretion and neurotoxicity from HIV-infected macrophages. Sci Rep. 2022 01 07; 12(1):233.

View in: PubMed

subject areas

Apoptosis
Cannabinoids
Cathepsin B
HIV Infections
HIV-1
Humans
Macrophages
Neurons
Receptor, Cannabinoid, CB2
Virus Replication

authors with profiles

Yamil Gerena
Loyda M. Meléndez

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support